Pito Chickering
Stock Analyst at Deutsche Bank
(4.43)
# 1,187
Out of 4,634 analysts
377
Total ratings
61.2%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Pito Chickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $107 → $98 | $97.78 | +0.22% | 18 | Aug 6, 2026 | |
| MDLN Medline | Rated: Hold | $42 → $37 | $33.81 | +9.44% | 4 | Aug 6, 2026 | |
| DVA DaVita | Rated: Buy | $220 → $265 | $183.69 | +44.26% | 22 | Aug 5, 2026 | |
| MD Pediatrix Medical Group | Rated: Hold | $19 → $25 | $26.08 | -4.14% | 20 | Aug 5, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $60 → $70 | $61.45 | +13.91% | 8 | Aug 3, 2026 | |
| BAX Baxter International | Maintained: Hold | $20 → $27 | $27.78 | -2.81% | 16 | Jul 31, 2026 | |
| LH Labcorp Holdings | Rated: Hold | $248 → $306 | $321.31 | -4.76% | 14 | Jul 31, 2026 | |
| OPCH Option Care Health | Downgraded: Hold | $26 → $24 | $24.50 | -2.04% | 18 | Jul 30, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $108 → $60 | $50.46 | +18.91% | 18 | Jul 30, 2026 | |
| HCA HCA Healthcare | Rated: Buy | $441 → $476 | $414.03 | +14.97% | 21 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $32 | $31.78 | +0.69% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $402 → $315 | $345.81 | -8.91% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $16 | $16.83 | -4.93% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $19.50 | +2.56% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9.5 | $5.22 | +81.99% | 18 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $11.74 | +87.39% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $12 | $9.46 | +21.56% | 11 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $94 | $92.03 | n/a | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $136 → $178 | $237.63 | n/a | 14 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.85 | $0.575 | n/a | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $26 → $18 | $0.015 | n/a | 13 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $241 | $325.98 | n/a | 12 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 → $240 | $172.74 | n/a | 16 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $79 → $85 | $89.41 | n/a | 21 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $95 | $125.81 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $259.93 | n/a | 17 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $62 | $29.39 | n/a | 1 | Apr 19, 2021 |
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: $107 → $98
Current: $97.78
Upside: +0.22%
Medline
Aug 6, 2026
Rated: Hold
Price Target: $42 → $37
Current: $33.81
Upside: +9.44%
DaVita
Aug 5, 2026
Rated: Buy
Price Target: $220 → $265
Current: $183.69
Upside: +44.26%
Pediatrix Medical Group
Aug 5, 2026
Rated: Hold
Price Target: $19 → $25
Current: $26.08
Upside: -4.14%
BrightSpring Health Services
Aug 3, 2026
Rated: Buy
Price Target: $60 → $70
Current: $61.45
Upside: +13.91%
Baxter International
Jul 31, 2026
Maintained: Hold
Price Target: $20 → $27
Current: $27.78
Upside: -2.81%
Labcorp Holdings
Jul 31, 2026
Rated: Hold
Price Target: $248 → $306
Current: $321.31
Upside: -4.76%
Option Care Health
Jul 30, 2026
Downgraded: Hold
Price Target: $26 → $24
Current: $24.50
Upside: -2.04%
Boston Scientific
Jul 30, 2026
Maintained: Buy
Price Target: $108 → $60
Current: $50.46
Upside: +18.91%
HCA Healthcare
Jul 27, 2026
Rated: Buy
Price Target: $441 → $476
Current: $414.03
Upside: +14.97%
May 1, 2026
Maintained: Buy
Price Target: $26 → $32
Current: $31.78
Upside: +0.69%
May 1, 2026
Maintained: Hold
Price Target: $402 → $315
Current: $345.81
Upside: -8.91%
Apr 30, 2026
Maintained: Hold
Price Target: $18 → $16
Current: $16.83
Upside: -4.93%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $19.50
Upside: +2.56%
Feb 25, 2026
Maintained: Hold
Price Target: $9.5
Current: $5.22
Upside: +81.99%
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $11.74
Upside: +87.39%
Sep 15, 2025
Maintained: Buy
Price Target: $7 → $12
Current: $9.46
Upside: +21.56%
Jul 25, 2025
Maintained: Buy
Price Target: $85 → $94
Current: $92.03
Upside: n/a
Jul 23, 2025
Maintained: Hold
Price Target: $136 → $178
Current: $237.63
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $5 → $2.85
Current: $0.575
Upside: n/a
Nov 8, 2024
Rated: Hold
Price Target: $26 → $18
Current: $0.015
Upside: n/a
Oct 31, 2024
Maintained: Buy
Price Target: $205 → $241
Current: $325.98
Upside: n/a
Oct 28, 2024
Reiterated: Buy
Price Target: $208 → $240
Current: $172.74
Upside: n/a
Aug 20, 2024
Reiterated: Hold
Price Target: $79 → $85
Current: $89.41
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $83 → $95
Current: $125.81
Upside: n/a
Jul 24, 2024
Rated: Buy
Price Target: $155
Current: $259.93
Upside: n/a
Apr 19, 2021
Maintained: Hold
Price Target: $62
Current: $29.39
Upside: n/a